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Edited by Irmgard SinningAbstract Structural characterization of membrane proteins is
hampered by the instability of the isolated proteins in detergent
solutions. Here, we describe a new class of phospholipid-like sur-
factants that stabilize the G protein-coupled receptor, BLT1.
These compounds, called C13U9, C13U19, C15U25 and C17U16,
were synthesized by radical polymerization of Tris(hydroxy-
methyl) acrylamidomethane in the presence of thioglycerol, ﬁrst
endowed with two hydrocarbon chains with variable lengths (13–
17 carbon atoms), as transfer reagent. C13U19, C17U16 or C15U25
signiﬁcantly enhanced the stability of BLT1 in solution com-
pared to what was obtained with common detergents. These mol-
ecules therefore represent a promising step towards the
structural characterization of BLT1 and possibly other mem-
brane proteins.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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G protein-coupled receptors are versatile biological sensors
that are responsible for the majority of cellular responses to
hormones and neurotransmitters as well as for the senses of
sight, smell and taste [1,2]. Although signiﬁcant progress has
been made within the last few years in dissecting GPCR-med-
iated signal transduction pathways [3], understanding the
mechanisms underlying ligand recognition and signal trans-
duction through the membrane has been hampered by the lack
of information at the molecular level. Structural information
on the GPCR family is therefore very sparse, with the excep-Abbreviations: AIBN, a,a 0-azobis isobutyronitrile; CD, circular
dichroism; cmc, critical micellar concentration; DDM, dodecyl-b-D-
maltoside; DPn, degree of polymerization; GPCRs, G protein-coupled
receptors; HDM, hexadecyl-b-D-maltoside; LDAO, dodecyldimeth-
ylamino oxide; LTB4, leukotriene B4; TEA, triethylamine; THAM,
Tris(hydroxymethyl)acrylamidomethane; THF, tetrahydrofuran
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doi:10.1016/j.febslet.2007.03.091tion of rhodopsin for which several crystal structures have
been determined [4–6], and therefore appears as the structural
prototype of G protein-coupled receptors (GPCRs).
The primary diﬃculty encountered in the study of mem-
brane proteins such as GPCRs is that of obtaining the protein
of interest. GPCRs are usually present at low levels in biolog-
ical membranes, and it is rare that a single protein species is a
major peptidic constituent of the membrane. Furthermore,
membrane proteins are naturally embedded in a lipid bilayer,
which is a complex and heterogeneous environment. Finally,
membrane proteins are generally not soluble in aqueous solu-
tion. The need for membrane proteins to be maintained in sur-
roundings that satisfy their high hydrophobicity therefore
requires special synthetic systems for in vitro work [7]. Unfor-
tunately, reconstituting puriﬁed proteins into such systems has
proven to be non-trivial (for a review, see [7]). Maintaining
membrane proteins in aqueous solutions, in particular in the
context of crystallization assays, is therefore of major scientiﬁc
and biomedical importance. While classical phospholipids nat-
urally associate with membrane proteins without inducing any
unfolding, they cannot be used to maintain them soluble be-
cause of their own poor solubility in aqueous solutions. To
alleviate the major problem of membrane protein unfolding,
aggregation and/or inactivation by classical detergents, less
aggressive surfactants such as amphipols [8,9] or ﬂuorinated
surfactants [10–13] have been designed and are currently devel-
oped. Non-ionic ﬂuorinated surfactants as well as amphipols
do not solubilize biological membranes but are able to keep
membrane proteins that have been extracted using classical
surfactants soluble in water. The possibility of using such sur-
factants to maintain the native fold of the BLT1 receptor in
solution is currently under investigation. Despite the promis-
ing results obtained with these molecules, the search for surfac-
tant molecules that could stabilize the native fold of membrane
protein better than commercial detergents do is still crucial in
the context of membrane protein structural analyses.
We have produced a GPCR, the BLT1 receptor, as a recom-
binant protein in an E. coli expression system with yields
allowing structural studies to be carried out [14]. BLT1 is
one of the two membrane receptors for leukotriene B4 [15].
Leukotriene B4 (LTB4) is a potent activator and chemoattrac-
tant for leukocytes and is involved in several inﬂammatory
diseases [16]. BLT1 therefore represents an important targetblished by Elsevier B.V. All rights reserved.
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considered as a typical class A GPCR with a diﬀusible ligand
and the results with this receptor could therefore be extended
to other members of this class of receptors. As stated above,
structural analyses require BLT1 to be stable in detergent solu-
tions for periods of time compatible with such studies, in par-
ticular with crystallization assays. Indeed, any conformational
heterogeneity arising from a partial unfolding of the puriﬁed
receptor could be detrimental to crystallization. To achieve
the highest stability of recombinant BLT1 in solution, we
tested here the ability of a series of original surfactants to sta-
bilize the recombinant receptor in vitro compared to what is
usually obtained with common detergents.2. Materials and methods
2.1. Materials
LTB4 was purchased from BIOMOL Laboratories. Fos-choline-16
was from Anatrace and thrombin from Sigma. The solvents and chem-
icals for the detergent synthesis were obtained from commercial
sources (Aldrich, Acros Organics, Lancaster (UK)). They were of re-
agent grade and were used without further puriﬁcation. 1,6-Diphe-
nyl-1,3,5-hexatriene and carboxyﬂuorescein were purchased from
ACROS and used without further puriﬁcation.
2.2. Buﬀers
Buﬀer A: 100 mMNaH2PO4, 10 mM Tris–HCl, 10% glycerol, 4 mM
2-mercaptoethanol, 0.4% SDS, pH 8. Buﬀer B: 12.5 mM Na-borate,
10 mM NaCl, pH 7.8 containing the detergent and asolectin (1:2 lipid
to detergent ratio). All the surfactants were used at concentrations cor-
responding to 1.5 times their critical micellar concentration (cmc) (see
Table 1).
2.3. Detergent synthesis
2.3.1. General methods. Analytical TLCs were carried out on pre-
coated Silica Gel 60F-254 plates (Merck) and visualization was per-
formed with UV light (254 nm), ninhydrine spraying and heating
(2% in ethanol) and sulfuric acid spraying and heating (2% in ethanol).
Flash chromatographies were performed on Geduran Si 60 (40–63 lm)
silica gel from Merck. Spectra were recorded using the following
instruments. For 1H, 13C and 19F NMR spectra: Brucker AC 250;
for mass spectra: JEOL DX 300.
2.3.2. Synthesis of lipidomimetics. These compounds were synthe-
sized from the thioglycerol as starting material. First, S-trityl mercapto
glycerol was prepared in high yield by grafting triphenyl methyl chlo-
ride onto thiol function of thioglycerol in tetrahydrofuran (THF) at
0 C in a presence of triethylamine (TEA). Then, the hydrophobic tails
were grafted onto the hydroxyl functions of the thioglycerol residue:
this was achieved through carbamate bonds by using the chosen car-
boxylic acid (myristic, palmitic or stearic acid) in the presence of diph-
enylphosphorylazide and TEA in toluene at 60 C. The action of
diphenylphosphorylazide on carboxylic acid leads to an alkyl isocya-
nate that immediately reacts with hydroxyl functions of thioglycerol
moiety. The protective trityl group was then cleaved in an acidic
medium at room temperature (triﬂuoroacetic acid–dichloromethaneTable 1
Physical–chemical data of CnUm surfactants
Compound R R0 DPn MW (g mol
1) Yield (%
4a1 C13U9 C13H27 6 9 2200 75
4a2 C13U19 C13H27 14 19 3850 78
4b C15U25 C15H31 17 25 4960 91
4c C17U16 C17H35 15 16 3440 89
Diameter (1) is the diameter of the surfactant in the buﬀer used for refoldin
protein:surfactant complex measured under the same conditions. R0 is the
polymerization of each compound. Cmc means critical micellar concentratio1/1 v/v). Thus, telomerization of Tris(hydroxymethyl)acrylamido-
methane in a presence of this hydrophobic thiol molecule as telogen
was performed in a THF/methanol mixture at 65 C under an argon
atmosphere, using a,a 0-azobis isobutyronitrile (AIBN) as radical initi-
ator. The AIBN concentration in the reaction mixture was roughly ten
times lower than the thiol molecule (called telogen) [17].
The number average degree of polymerization is equal to the
amount of repeating Tris(hydroxymethyl)acrylamidomethane
(THAM) units n. With a given transfer reagent, it may vary from
one (monoadduct) to several tens, depending on the [monomer]/[telo-
gen] ratio (R0) adjusted through both starting material and experimen-
tal conditions [18]. The proportions of monomer THAM and thiol
3a–c (telogen) used are reported in Table 1. These proportions were
chosen taking into account previous results obtained with THAM telo-
merization and structural relationships between degree of polymeriza-
tion (DPn) and supramolecular systems obtained in water (Michel, N.,
unpublished data). Each experiment was pursued until the complete
disappearance of the monomer. At the end of polymerization, the sol-
vents were removed under vacuum, the remaining telomer was solubi-
lized in a small amount of methanol, then dropped in ethyl ether. The
precipitate was ﬁltered oﬀ and then submitted to a size exclusion chro-
matography using a Sephadex G25 column and then lyophilized. The
DPn of the macromolecule, was determined in
1H NMR by comparing
peaks area assigned to the terminal methyl signals in the hydrocarbon
tails (d 0.9 ppm, integral 6H) to hydroxyl groups of THAM (d 5 ppm,
integral 3nH).
2.3.3. Determination of the cmc by ﬂuorescence measurements. The
cmc of the CnUm surfactants was determined from steady-state ﬂuores-
cence measurement [19]. Measurements were carried out at 25 ± 0.1 C
on a SPEX-Fluoromax 2 ﬂuorimeter (Jobin-Yvon). Fluorescence emis-
sion spectra of samples containing 1.6 lM pyrene were recorded using
an excitation wavelength of 335 nm. Emission intensities were recorded
at k1 = 373 nm and k3 = 384 nm [19]. For each surfactant, the cmc val-
ues was the average of three independent measurements.
2.3.4. Dynamic light scattering. Particles size and polydispersity
were measured at 25 C using a Zetasizer Nano-S model 1600 (Mal-
vern Instruments Ltd., UK) equipped with a He–Ne laser
(k = 633 nm, 4.0 mW). The Stokes radius (RS) of the particles was esti-
mated from their diﬀusion coeﬃcient (D) using the Stokes–Einstein
equation D = kBT/6pgRS, where kB is Boltzmann constant, T the abso-
lute temperature and g the viscosity of the solvent.
2.4. BLT1 refolding
The unfolded BLT1 receptor was prepared as recently described [20].
The unfolded His-tagged BLT1 in buﬀer A was loaded again on a Ni-
NTA matrix and immobilized at a protein-to-resin ratio of 0.5–0.6 mg
of protein/ml of hydrated Ni-NTA agarose, and refolding was
achieved by using linear gradient from buﬀer A to buﬀer B. Dissocia-
tion of BLT1 from the matrix was then achieved with buﬀer B contain-
ing 300 mM imidazole. Unfolded proteins were discarded and the
functional receptor further puriﬁed by gel ﬁltration chromatography
on a Superdex S200 HR column (1.6 · 70 cm) using buﬀer B as the elu-
ent. The amounts of dimeric receptor were estimated by chemical
cross-linking, as described previously [21].
2.5. Circular dichroism measurements
Circular dichroism (CD) spectra were recorded at 22 C with a dich-
rograph CD6 (Jobin-Yvon). The spectra are the average of ﬁve scans
using a bandwidth of 2 nm, a step-width of 0.2 nm and a 0.5 s averag-
ing time per point. The cell path length was 1.00 ± 0.01 mm. BLT1) cmc (lM ± S.D.) Diameter1 (nm) Diameter2 (nm)
7.9 ± 0.7 6.2 ± 0.3 10.3 ± 0.4
8.1 ± 0.8 8.5 ± 0.2 12.5 ± 0.3
5.5 ± 0.7 9.1 ± 0.3 13.3 ± 0.3
4.9 ± 0.4 8.1 ± 0.3 12.1 ± 0.2
g as measured by dynamic light scattering; Diameter (2) is that of the
[Monomer]0/[Telogen]0 ratio, DPn is the number average degree of
n (measured in pure deionized water at 25 C).
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ity of 5.0 · 104 L mol1 cm1 at 270.5 nm [22] was adopted for LTB4
without any correction for solvent eﬀects. The R factor in Fig. 4B is
the ratio of the intensity of the LTB4-associated CD maximum at
270.5 nm in the presence of saturating concentrations in BLT1 to that
measured in the absence of receptor.
2.6. LTB4 binding assays
The LTB4-associated CD band at 270.5 nm was selected for moni-
toring the binding (titrations using other CD maxima gave identical re-
sults). Successive additions of BLT1 were carried out whereas the
LTB4 concentration remained nearly constant (usually 10
8 M; dilu-
tion eﬀects not exceeding 3%). Binding isotherms were obtained by
plotting ([h]  [h]0)/([h]max  [h]0) as a function of BLT1 concentration,
where [h]max, [h]0 and [h] correspond to the molar ellipticities, at satu-
ration, zero occupancy and intermediate occupancy, respectively. The
binding parameters were inferred from these titration data by analyz-
ing them with the PRISM software (Graphpad Inc.) and considering a
set of usual models for describing the interaction.
2.7. Stability assays
The amount of active receptor as a function of time was determined
by circular dichroism. The intensity of LTB4-associated CD band cen-
tered at 270.5 nm in the presence of BLT1 was recorded at increasing
time values. The intensity of this band is directly related to the amount
of LTB4 bound to the receptor. The experimental conditions for these
CD measurements were those described above for the LTB4 binding
assays.Fig. 1. Chemical structure of THAM derived CnUm surfactants.
Fig. 2. Synthetic pathway of THA3. Results and discussion
We have combined chemical and biochemical methods to
design and test new molecules aimed at stabilizing the BLT1
receptor, and potentially other GPCRs, in vitro. Our starting
hypothesis was to consider that water-soluble non-ionic surfac-
tants, endowed with two hydrophobic tails, could mimic natu-
ral phospholipids, associate with membrane proteins and
maintain them soluble in aqueous solution without prohibitive
unfolding. We therefore synthesized a new family of synthetic
lipids harboring two hydrophobic tails with variable lengths.
These hydrocarbon chains were grafted onto the hydroxyl
groups of a thioglycerol interface by carbamate groups
(Fig. 1). In order to provide a higher solubility in water, the
polar head was prepared by radical polymerization of
Tris(hydroxymethyl) acrylamidomethane in the presence of
this thioglycerol derived transfer reagent [10]. The chemical
pathway is described in Fig. 2. Such a chemical pathway al-
lowed us to produce original lipid-like surfactants that make
micelles of well-deﬁned size in solution, as assessed by light
scattering experiments (the main physical–chemical data of
the CnUm surfactants, where n represents the number of car-
bon atoms of each hydrophobic chain and m the number of
Tris motives constituting the polar head – are reported in Ta-
ble 1). In water these compounds lead to micellar systems that
exhibit an average diameter larger than that observed with
classic detergents. If this slight increase in the micelle size is
a problem for future crystallization assays remains an open
question. If this is the case, one could for example envisage
the use of small amphiphiles molecules [23] or to modify the
nature of the polar head to reduce the micelle size.
The recombinant BLT1 receptor was refolded using the ma-
trix assisted-method we devised [14]. Brieﬂy, the unfolded
receptor was bound to a Ni-NTA matrix and then the denatur-
ing detergent (SDS) was progressively replaced by the
non-denaturing detergent. The receptor was subsequently
recovered from the Ni-NTA matrix and the unfolded fractionsM derived CnUm surfactants.
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tion of refolded receptor in Fig. 3A is the ratio of the amount
of receptor that is able to bind LTB4 to that initially bound to
the Ni-NTA matrix.
We ﬁrst tested the ability of the CnUm surfactants to increase
receptor refolding eﬃciency. In these assays, we replaced the
commercially available detergent that gave the best refolding
ratios, i.e. LDAO [14], hexadecyl-b-D maltoside (HDM) [21]
or fos-choline C-16 (unpublished data), by C13U9, C13U19,
C15U25 or C17U16. We previously showed in the case of a com-
mon detergent, LDAO, that using detergent at high concentra-
tions, i.e. above 2 times its cmc, results in a decreased refolding
ratio [14]. A similar behavior was observed with other common
detergents such as dodecyl-b-D-maltoside (DDM) (Bane`res,Fig. 3. Refolding and dimerization of the BLT1 receptor. (A)
Refolding ratio obtained for BLT1 in diﬀerent surfactants. The
refolding ratio corresponds to the amount of active, ligand-competent,
receptor after refolding to the amount of unfolded receptor before
refolding (see Section 2). (B) Receptor dimer amount after refolding in
the diﬀerent detergents as determined by chemical cross-linking.unpublished data). Although we did not investigate here the ef-
fects of the CnUm concentration on the refolding ratio, these
compounds were used at concentrations below this 2· cmc lim-
it. In all the cases, the surfactant was used in combination with
a mixture of natural lipids from soybean (see Section 2). Like
for common detergents (Bane`res, unpublished data), adding
the lipids increased the stability of the refolded receptor (see
Fig. 5 for C15U25; a similar behavior was observed with the
other surfactants). The fact that lipids are required for an opti-
mal stability of the receptor could seem contradictory with the
fact that our surfactants are designed to mimic phospholipids.
A possibility would be that some speciﬁc lipids are present in
the asolectin extract that are required to stabilize the receptor
and cannot be mimicked by our surfactant.
As shown in Fig. 3A, no signiﬁcant change in the refolding
eﬃciency was obtained after refolding the receptor in either
C13U19, C15U25 or C17U16 compared to what was achieved
in fos-choline-16. In all the cases, a maximal refolding ratio
of about 25–30% was obtained. Only C13U9 gave a dramati-
cally decreased refolding ratio (ca. 8–10%). We previously re-
ported that one of the main factors inﬂuencing the refolding
eﬃciency of BLT1 was the length of the alkyl chain of the
detergent [14]. Indeed, similar refolding ratios were obtained
with diﬀerent detergents with alkyl chain above C12, whereas
decreasing the length of the chain below this value dramati-
cally decreased refolding eﬃciency [14]. For example, a ca.
10-fold increase in the refolding ratio was obtained when using
dodecyldimethylamino oxide (LDAO) instead of undecyldim-
ethylamino oxide whereas similar refolding ratios were ob-
tained with LDAO and tridecyldimethylamino oxide. Such a
behavior could explain why the diﬀerent surfactants produced
here that display alkyl chains ranging from 13 to 17 carbon
atoms lead to similar refolding ratios.
The functional species in the case of GPCRs are likely to be
the dimer [24]. If this is really the case, stabilization of this
assembly will be required for analyzing the structural and
functional features of the puriﬁed receptors. We previously
showed that the stability of the BLT1 dimer was highly depen-
dent on the nature of the detergent [21]. We analyzed here the
oligomerization state of the receptor refolded in the diﬀerent
CnUm surfactants using the cross-linking approach described
previously [21]. As shown in Fig. 3B, the dimer is the predom-
inant species whatever the surfactant used is, with the excep-
tion of C13U9 where the refolded receptor appears as a
mixture of monomer and dimer in ca. similar amounts. This
indicates that all our surfactants besides the one with the short-
er polar head, i.e. C13U9, essentially stabilize the BLT1 dimeric
assembly. As stated above, we previously showed that increas-
ing the length of the alkyl chain not only led to higher refold-
ing ratios but also to an increased stabilization of the BLT1
dimer [22]. In agreement with this result, it has also been re-
cently shown that detergents with long alkyl chains, i.e. above
C12, lead to a better stabilization of rhodopsin oligomers [25].
The apparent eﬀect of the length of the alkyl chain of the CnUm
surfactants on the dimer stability is thus in full agreement with
our previous observations with common detergents.
We next analyzed the structural and functional properties of
BLT1 refolded in the diﬀerent surfactants described above.
BLT1 retains its structural features whatever the surfactant
used for refolding is. Indeed, in all the cases, the circular
dichroism (CD) spectrum of the refolded receptor in the
200–250 nm region was that of a well-folded protein with a
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for BLT1 refolded in LDAO (not shown). The ligand binding
properties of the receptor were assessed by measuring the
changes in the dichroic properties of LTB4 induced by the
binding to BLT1. As previously reported [14], free LTB4 is
characterized by a four-band CD spectrum in the 240–
290 nm region (Fig. 4A). Binding to the recombinant receptor
results in an increase in the intensity of all LTB4 dichroic
bands that can be interpreted as a skewing of the time-aver-Table 2
Ligand binding properties of the refolded receptor
Surfactants C13U9 C13U19
Kd LTB4 (nM) 13.9 ± 2.2 12.5 ± 1.8
Ki U75302 (nM) 217 ± 16 212 ± 12
These values were determined from the CD-monitored titration plots as descr
from the mean value calculated from three experiments.
Fig. 4. LTB4 binding to refolded BLT1. (A) Near-UV circular
dichroism spectrum of LTB4 free (1) or bound to the BLT1 receptor
refolded in fos-choline-16 (2). (B) CD increase ratio R obtained for the
BLT1 receptor refolded in the diﬀerent detergents. R is the ratio of the
LTB4-associated CD intensity at 270.5 nm in the presence of BLT1 to
that measured in the absence of BLT1. The error values correspond to
the standard deviation from the mean value calculated from three
experiments.aged planar triene in free LTB4. As shown in Fig. 4B, the in-
crease in the intensity of the dichroic bands of LTB4
observed in the presence of the puriﬁed BLT1 was similar
whatever the surfactant used for refolding the receptor was.
Even moderate deviations from planarity in the triene motif
of LTB4 cause intense changes in the CD spectra [26]. The
changes in the CD properties associated with the triene moiety
of LTB4 are therefore very sensitive to subtle changes in the
torsional features of this triene. The similarity in the intensity
of the LTB4-associated CD bands observed with the receptor
refolded in the diﬀerent surfactants is thus direct evidence that
the structural features of BLT1-bound LTB4 are the same.
This is strongly indicative of a similarity in the three-dimen-
sional structural features of the receptor refolded in the diﬀer-
ent surfactants.
The increase in the intensity of the LTB4-associated CD
bands can be used to monitor the binding of LTB4 to BLT1,
as well as the competition between a BLT1-speciﬁc antagonist
molecule, U-75302, and LTB4 for binding to BLT1 [14]. We
next measured the respective Kd and Ki values obtained from
the CD-monitored with BLT1 refolded in C13U9, C13U19,
C15U25 or C17U16 or fos-choline-16. As shown in Table 2, these
diﬀerent surfactants stabilize very similar functional states of
the receptor. These ligand binding properties of the refolded
receptor in the CnUm surfactants are also closely related to
those determined for the receptor expressed in eukaryotic cell
[15] indicating that, in all the surfactants used here, the recom-
binant BLT1 receptor is likely to adopt its native fold. It is to
be noted that the receptor refolded in C13U9 bound its ligands
with aﬃnity values closely related to those measured for the
receptor in the other CnUm surfactants, although being present
in the solution as a mixture of monomer and dimer. This is
consistent with our previous observation that receptor dimer-
ization has no signiﬁcant eﬀect on the binding of the ligands
to the puriﬁed BLT1 receptor [27].
We ﬁnally analyzed the time-dependent stability of BLT1 re-
folded in the diﬀerent detergents. To this end, we followed the
ligand-competent receptor fraction as a function of time. The
ligand-binding properties of the BLT1 receptor were assessed
by circular dichroism, as described above. Fig. 5 shows the per-
cent of active receptor as a function of time. When the receptor
was refolded in fos-choline-16 or LDAO, a signiﬁcant decrease
in the functional fraction was observed after a 10-day period so
that, after about 20 days, only 50% of the receptor was able to
bind the LTB4 agonist with high aﬃnity. A similar behavior
was observed when the receptor was refolded in either
DDM/asolectin or HDM/asolectin mixtures (not shown).
The decrease in the amount of active receptor probably reﬂects
the unfolding of the receptor under the conditions used. In
agreement with this hypothesis, a concomitant decrease in
the molar ellipticity at 222 nm in the CD spectrum of the
receptor was observed, as shown in the inset to Fig. 5 for the
receptor in LDAO or C15U25 (a similar behavior was observedC15U25 C17U16 fos-choline C16
13.6 ± 2.1 12.1 ± 1.6 13.1 ± 1.3
203 ± 15 219 ± 11 208 ± 17
ibed in Section 2. The error values correspond to the standard deviation
Fig. 5. Time-dependent ligand-binding properties of BLT1. The
amount of ligand-competent receptor refolded in the diﬀerent surfac-
tants was assessed by circular dichroism as a function of time (see
Section 2). All the curves correspond to refolding in the presence of the
surfactant and asolectins, with the exception of the open diamonds
that correspond to the refolding in the presence of only C15U25 without
asolectins. Closed triangles: C13U9; open squares: LDAO; closed
squares: fos-choline-16; closed circles: C13U19; open circles: C17U16;
open triangles: C15U25. Inset: variations in the intensity at 222 nm in
the CD spectrum of the receptor refolded in either LDAO (open
squares) or C15U25 (open triangles) as a function of time.
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refolded with C13U9 as a surfactant, receptor unfolding started
as soon as 5–6 days. In contrast, reconstituting the BLT1
receptor in C13U19, C17U16 or C15U25 allowed a signiﬁcant in-
crease in its time-dependent stability. In particular, when
reconstituted in C15U25, BLT1 was stable with no signiﬁcant
unfolding up to 16–17 days, as compared to 10–12 days in
the case of fos-choline-16 or LDAO. This shows that refolding
of the BLT1 receptor in this surfactant signiﬁcantly increases
its time-dependent stability with no change in either its func-
tional or structural properties.
The data reported here therefore clearly establish that the
C13U19, C17U16 or C15U25 surfactants can be favorably used
to increase the stability of the native fold of the recombinant
receptor BLT1. Moreover, as clearly stated in Table 2, light
scattering measurements with the refolded receptors in any
of these surfactants clearly indicate that the puriﬁed receptor
under theses conditions is monodisperse with deter-
gent:lipid:protein complexes of well-deﬁned size (the light scat-
tering experiments were carried out after 5 days of storage, at a
point where no loss of function of the receptor was observed;
see Fig. 5). The absence of polydispersity could be an interest-
ing feature in a crystallization perspective.
It is to be noted that a direct comparison of the eﬀects of the
length of the alkyl chains and the nature of the polar head-
group of the diﬀerent surfactants on BLT1 stability can be car-
ried out since they all display cmc values in the same range.
The surfactants we produced display the general features of
phospholipids with two hydrophobic tails grafted on a polar
head but still make micelles as detergents do. Although not
aﬀecting the global refolding eﬃciency, these CnUm surfactants
stabilize the functional state of the puriﬁed receptor better
than any of the common detergents we tested so far. Such a re-
sult therefore validates our starting hypothesis postulating that
phospholipid-like surfactants could associate with membraneproteins and maintain them soluble in aqueous solution with-
out reduced unfolding better than common detergents.
Besides the length of the alkyl chain that seems to play an
important role on receptor stability [14], the data obtained
with the diﬀerent surfactants we produced indicate that, above
a certain length of the alkyl chain, the nature of the hydro-
philic head could also contribute to the stabilization of the
membrane protein in its native fold in solution. Indeed, a sig-
niﬁcant increase in the stability of BLT1 was achieved with
C13U19 compared to what was observed with C13U9. Similarly,
a slightly higher stability was achieved in C15U25 compared to
what was obtained with C17U16 even if the alkyl chain of the
latter is longer than that of the former. The reason for such
a diﬀerence is still unclear. It is to be noted that the geometrical
features of the micelle, in particular its size, are aﬀected by the
nature of the polar head (see Table 1). The diﬀerence is partic-
ularly striking between C13U9 and C13U19. If this is the reason
for the increased stability of the recombinant BLT1 is an open
question.
It is to be noted that the surfactants that lead to an increased
stability of the refolded BLT1 also favor the dimeric state of
the receptor, whereas C13U9, that is a poor surfactant in the
context of BLT1 stability, also leads to the occurrence of mix-
tures of monomeric and dimeric receptors. However, a direct
relationship between dimerization and stability of BLT1 in
solution cannot be directly drawn since in fos-choline C-16
the receptor is also essentially dimeric but less stable than in
C15U25. Therefore, although stabilization of the dimer may
contribute to the global stability of BLT1, it is not likely to
be the driving force for such stabilizing eﬀects.
Stabilizing the native fold of G protein-coupled receptors in
the context of structural studies is of crucial importance if we
consider the dramatic lack of structural information on these
receptors that are considered so far as the most important tar-
gets in the context of drug discovery [28]. Although we and
others have developed during the last years an approach that
allows the production of GPCRs in high yields through
in vitro refolding of bacterially expressed proteins [14,29,30],
stabilizing the refolded receptor in a native conformation in
solution is still a problem. On the basis of the results obtained
with the BLT1 receptor, the new surfactant molecules de-
scribed in this work appear as promising tools to circumvent
such a problem.
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